You are here

Article info

Article menu
Download PDFPDF
EBM opinion and debate
Improving FDA postmarket adverse event reporting for medical devices

Authors

  • Susmitha Wunnava Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA Computational Health Informatics Program, Boston Children's Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Timothy A Miller Computational Health Informatics Program, Boston Children's Hospital, Boston, Massachusetts, USA Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Florence T Bourgeois Computational Health Informatics Program, Boston Children's Hospital, Boston, Massachusetts, USA Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Florence T Bourgeois, Boston Children's Hospital, Boston, MA 02115, USA; Florence.Bourgeois{at}childrens.harvard.edu
View Full Text

Citation

Wunnava S, Miller TA, Bourgeois FT
Improving FDA postmarket adverse event reporting for medical devices
BMJ Evidence-Based Medicine 2023;28:83-84.

Publication history

  • Accepted January 21, 2022
  • First published February 17, 2022.
Online issue publication 
March 23, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.